<p><h1>NGS-based RNA-sequencing Market Size, Share & Trends Analysis Report By Application, Regional Outlook, Competitive Strategies, And Segment Forecasts, 2024 - 2031</h1></p><p><strong>NGS-based RNA-sequencing Market Analysis and Latest Trends</strong></p>
<p><p>NGS-based RNA-sequencing is a powerful technology that allows researchers to analyze the transcriptome of a biological sample, providing valuable insights into gene expression patterns and regulatory mechanisms. This technique involves sequencing RNA molecules to identify and quantify the various transcripts present in a sample, enabling the study of gene expression levels, alternative splicing, and gene fusion events.</p><p>The NGS-based RNA-sequencing market is currently experiencing significant growth, driven by the increasing demand for personalized medicine, advancements in RNA-sequencing technology, and the rising focus on understanding gene expression in various diseases. The market is expected to grow at a CAGR of 9.8% during the forecast period, with key players in the industry investing in research and development to innovate new sequencing platforms and analysis tools.</p><p>The latest trends in the NGS-based RNA-sequencing market include the adoption of single-cell RNA-sequencing technology, the integration of AI and machine learning techniques for data analysis, and the development of targeted RNA-sequencing assays for specific applications. These trends are expected to drive further growth in the market as researchers seek to unlock the full potential of RNA-sequencing for understanding disease mechanisms and developing personalized therapies.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp;</strong> <a href="https://www.reliableresearchreports.com/enquiry/request-sample/1567103">https://www.reliableresearchreports.com/enquiry/request-sample/1567103</a></p>
<p>&nbsp;</p>
<p><strong>NGS-based RNA-sequencing Major Market Players</strong></p>
<p><p>The NGS-based RNA-sequencing market is highly competitive with key players such as Illumina, Thermo Fisher Scientific, Oxford Nanopore, Agilent Technologies, and BGI dominating the market. These companies have a strong presence in the market due to their advanced technologies, extensive product portfolios, and strong brand reputation.</p><p>Illumina is a leading player in the NGS market, offering a wide range of sequencing platforms and consumables. The company has experienced significant market growth over the years, driven by increasing adoption of NGS technologies in research and clinical applications. With continuous innovations and strategic collaborations, Illumina is expected to maintain its market leadership and drive future growth.</p><p>Thermo Fisher Scientific is another key player in the NGS-based RNA-sequencing market, with a diverse product portfolio that includes sequencing instruments, reagents, and software solutions. The company has witnessed steady market growth, attributed to its focus on developing advanced technologies and expanding its global presence. Thermo Fisher Scientific's strong market position and innovative products are likely to contribute to its future growth.</p><p>In terms of sales revenue, Illumina reported approximately $3.5 billion in revenue for the fiscal year 2020. Thermo Fisher Scientificâ€™s sales revenue for the same period was around $32 billion. These figures indicate the strong market presence and financial performance of these companies in the NGS-based RNA-sequencing sector.</p><p>Overall, the NGS-based RNA-sequencing market is expected to witness significant growth in the coming years, driven by increasing demand for personalized medicine, precision healthcare, and advancements in genomic research. Key market players such as Illumina and Thermo Fisher Scientific are well-positioned to capitalize on these opportunities and maintain their competitive edge in the market.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For NGS-based RNA-sequencing Manufacturers?</strong></p>
<p><p>The NGS-based RNA-sequencing market is experiencing significant growth, propelled by advancements in technology, increasing demand for personalized medicine, and rising investments in research and development activities. Key trends include the adoption of single-cell RNA-sequencing and the integration of AI and machine learning in data analysis. The market is expected to continue expanding at a rapid pace, with a projected CAGR of over 13% in the coming years. Factors such as the increasing prevalence of diseases, expanding applications in oncology and infectious diseases, and the emergence of novel sequencing platforms will drive further growth in the market.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report:</strong> <a href="https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1567103">https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1567103</a></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The NGS-based RNA-sequencing Market Analysis by types is segmented into:</strong></p>
<p><ul><li>Sequencing by Synthesis</li><li>Ion Semiconductor Sequencing</li><li>Single-molecule Real-time Sequencing</li><li>Nanopore Sequencing</li></ul></p>
<p><p>NGS-based RNA-sequencing market includes various types such as Sequencing by Synthesis, which involves sequencing DNA by detecting fluorescent signals during nucleotide incorporation; Ion Semiconductor Sequencing, which measures changes in pH as nucleotides are incorporated into DNA; Single-molecule Real-time Sequencing, where individual DNA molecules are sequenced in real-time; and Nanopore Sequencing, which passes DNA through nanopores to detect changes in electrical current. Each type offers unique advantages and applications in RNA sequencing research.</p></p>
<p><strong>Purchase this Report:&nbsp;</strong><a href="https://www.reliableresearchreports.com/purchase/1567103">https://www.reliableresearchreports.com/purchase/1567103</a></p>
<p>&nbsp;</p>
<p><strong>The NGS-based RNA-sequencing Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Research & Academia</li><li>Hospitals & Clinics</li><li>Pharmaceutical & Biotechnology Companies</li><li>Others</li></ul></p>
<p><p>NGS-based RNA-sequencing is widely utilized in various sectors including Research & Academia, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and others. In Research & Academia, it is used for studying gene expression and regulation. In Hospitals & Clinics, it aids in diagnosing and monitoring diseases. Pharmaceutical & Biotechnology Companies use it for drug development and personalized medicine. Other sectors may include forensic labs, agricultural research, and environmental studies where RNA-sequencing is utilized for various applications.</p></p>
<p>&nbsp;</p>
<p><strong>In terms of Region, the NGS-based RNA-sequencing Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The NGS-based RNA-sequencing market is poised for significant growth in the regions of North America (NA), Asia Pacific (APAC), Europe, the United States (USA), and China. Among these regions, North America and Europe are expected to dominate the market with a combined market share of approximately 60%. The United States is anticipated to hold the largest market share among individual countries, followed by China. The market in Asia Pacific is also projected to experience strong growth, driven by increasing adoption of NGS technologies in the region.</p></p>
<p><strong>Purchase this Report: </strong><a href="https://www.reliableresearchreports.com/purchase/1567103">https://www.reliableresearchreports.com/purchase/1567103</a></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;</strong><a href="https://www.reliableresearchreports.com/enquiry/request-sample/1567103">https://www.reliableresearchreports.com/enquiry/request-sample/1567103</a></p>
<p><strong></strong></p>
<p><p><a href="https://medium.com/@mariliehowe/anti-nuclear-antibody-test-market-size-market-outlook-and-market-forecast-2024-to-2031-03d84fc78e38">Anti-Nuclear Antibody Test Market</a></p><p><a href="https://medium.com/@leliajewess/analyzing-car-t-therapy-in-haematological-malignancy-market-global-industry-perspective-and-9f4009766aac">CAR-T Therapy in Haematological Malignancy Market</a></p><p><a href="https://medium.com/@josueherzog/dna-rna-extractor-market-trends-and-market-analysis-forecasted-for-period-2024-2031-8026630138af">DNA/RNA Extractor Market</a></p><p><a href="https://medium.com/@leliajewess/her2-human-epidermal-growth-factor-receptor-2-inhibitors-market-size-cagr-trends-2024-2030-415eb61ede3f">HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market</a></p><p><a href="https://medium.com/@mariliehowe/next-generation-biomanufacturing-market-trends-and-market-analysis-forecasted-for-period-2024-2031-cf1f07362d4a">Next-Generation Biomanufacturing Market</a></p></p>